Case Report: Infusion-Related Reactions to Intravenous Infliximab and Subcutaneous Ustekinumab in Pediatric Crohn's Disease

• Asıl Yazarlar: Toshihiko Kakiuchi (Yazar), Sakiko Kimura (Yazar), Motohiro Esaki (Yazar), Muneaki Matsuo (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Frontiers Media S.A., 2021-12-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Background: Although the biological agent ustekinumab (UST) is reported to be effective for Crohn's disease (CD) in pediatric as well as adult patients, data on the efficacy and safety of UST in pediatric patients with CD are limited. Here, we describe the case of a pediatric patient who showed...